14
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Phencyclidine: An Overview

, &
Pages 280-285 | Published online: 18 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

RichardE. Garey. (1979) PCP (Phencyclidine): An Update. Journal of Psychedelic Drugs 11:4, pages 265-275.
Read now
RobertL. Balster & RoxanneS. Pross. (1978) PHENCYCLIDINE: A Bibliography of Biomedical and Behavioral Research. Journal of Psychedelic Drugs 10:1, pages 1-15.
Read now

Articles from other publishers (17)

Audrey Redford. (2016) Don’t eat the brown acid: Induced ‘malnovation’ in drug markets. The Review of Austrian Economics 30:2, pages 215-233.
Crossref
Yoshiaki Miyamoto, Yukihiro Noda, Yumiko Komori, Hishayoshi Sugihara, Hiroshi Furukawa & Toshitaka Nabeshima. (2000) Involvement of nitric oxide in phencyclidine-induced place aversion and preference in mice. Behavioural Brain Research 116:2, pages 187-196.
Crossref
Kiyoyuki Kitaichi, Yukihiro Noda, Yoshiaki Miyamoto, Atsushi Numaguchi, Hirokatsu Osawa, Takaaki Hasegawa, Hiroshi Furukawa & Toshitaka Nabeshima. (1999) Involvement of the serotonergic neuronal system in phencyclidine-induced place aversion in rats. Behavioural Brain Research 103:1, pages 105-111.
Crossref
Rhea E Steinpreis, Katie A Anders, Emily M Branda & Catherine K Kruschel. (1999) The Effects of Atypical Antipsychotics and Phencyclidine (PCP) on Rotorod Performance. Pharmacology Biochemistry and Behavior 63:3, pages 387-394.
Crossref
TOSHITAKA NABESHIMA, KIYOYUKI KITAICHI & YUKIHIRO NODA. (1996) Functional Changes in Neuronal Systems Induced by Phencyclidine Administration. Annals of the New York Academy of Sciences 801:1 Cellular and, pages 29-38.
Crossref
Rhea E. Steinpreis. (1996) The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis. Behavioural Brain Research 74:1-2, pages 45-55.
Crossref
Kiyoyuki Kitaichi, Kiyofumi Yamada, Yukio Yoneda, Kiyokazu Ogita, Takaaki Hasegawa, Hiroshi Furukawa & Toshitaka Nabeshima. (1995) Risperidone prevents the development of supersensitivity, but not tolerance, to phencyclidine in rats treated with subacute phencyclidine. Life Sciences 56:7, pages 531-543.
Crossref
R.E. Steinpreis & J.D. Salamone. (1993) The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study. Brain Research 612:1-2, pages 263-270.
Crossref
Alphonse Poklis, Diane Maginn & Judith L. Barr. (1987) Drug findings in ‘driving under the influence of drugs’ cases: A problem of illicit drug use. Drug and Alcohol Dependence 20:1, pages 57-62.
Crossref
Marilyn E. Carroll. (1984) Effects of pentobarbital and d-amphetamine on oral phencyclidine self-administration in rhesus monkeys. Pharmacology Biochemistry and Behavior 20:1, pages 137-143.
Crossref
G. A. Brine, K. G. Boldt, M. L. Coleman & F. I. Carroll. (2009) Carbon‐13 nuclear magnetic resonance spectra of phencyclidine analogs substituted in the piperidine and aromatic rings. Journal of Heterocyclic Chemistry 21:1, pages 71-75.
Crossref
James Cleary, Juan Herakovic & Alan Poling. (1981) Effects of phencyclidine on shock-induced aggression in rats. Pharmacology Biochemistry and Behavior 15:5, pages 813-818.
Crossref
David W. Beaudry & James E. Lennon. (1980) Angel dust: Implications for child care agencies. Child Care Quarterly 9:4, pages 258-264.
Crossref
Charles R. Martin & Henry. Freiser. (2002) Ion-selective electrode for the determination of phencyclidine. Analytical Chemistry 52:11, pages 1772-1774.
Crossref
G. A. Brine, E. E. Williams, K. G. Boldt & F. I. Carroll. (2009) Carbon‐13 nuclear magnetic resonance spectra of phenycyclidine analogs. Journal of Heterocyclic Chemistry 16:7, pages 1425-1429.
Crossref
Richard Bunce. (1979) Social and Political Sources of Drug Effects: The Case of Bad Trips on Psychedelics. Journal of Drug Issues 9:2, pages 213-233.
Crossref
Audrey Redford. (2015) Don't Eat the Brown Acid: Induced Malnovationn in Drug Markets. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.